A Harvard-led study of 130 hypertensive individuals found a unique home-based blood pressure (BP) control program run by non-physicians can help patients reach healthy BP goals within seven weeks.

The FDA is looking into the signal of increased late mortality associated with paclitaxel-coated balloons and stents that was observed in a recent meta-analysis of patients treated for femoropopliteal artery disease.

Older age, smoking and a higher body mass index (BMI) were consistently associated with a heightened risk of venous thromboembolism (VTE) in an analysis of 1.1 million individuals published in JAMA Cardiology.

The nature of caregiving means the caregiver-patient relationship is always changing, but continued support from a network of experts and dedication to mutuality and preparedness can ensure both patients and caregivers have a good quality of life (QoL), according to a study published Jan. 14 in Circulation: Cardiovascular Quality and Outcomes.

Research published in the Journal of the American Heart Association Jan. 13 has concluded administering PCSK9 inhibitors to acute MI patients ahead of ischemia can mitigate the potential negative neurological effects that come with treatment.

Hong Kong researchers have identified “a previously unknown burden” of mental illness among those with young-onset type 2 diabetes (YOD), with a study suggesting more than one-third of days those patients spend in the hospital before age 40 can be attributed to mental health.

Measuring blood levels of vaspin could independently predict major adverse cardiac events (MACE) in patients who have suffered acute myocardial infarction (AMI), according to research published Jan. 16 in the Journal of the American Heart Association, potentially improving early risk stratification in heart attack survivors.

Abbott plans to acquire Cephea Valve Technologies, a company developing a transcatheter mitral valve replacement (TMVR) device, the Chicago-area healthcare giant announced Jan. 16.